ÖZKAN, M. 2013. Predictive significance of VEGF and HIF-1 alpha expression in metastatic colorectal cancer patients receiving chemotherapy combined with bevacizumab. Journal of clınıcal oncology , (*, United States Of America).

ÖZKAN, M., (2013). Predictive significance of VEGF and HIF-1 alpha expression in metastatic colorectal cancer patients receiving chemotherapy combined with bevacizumab . Journal of clınıcal oncology, *, United States Of America

ÖZKAN, METİN. "Predictive significance of VEGF and HIF-1 alpha expression in metastatic colorectal cancer patients receiving chemotherapy combined with bevacizumab," Journal of clınıcal oncology, *, United States Of America, 2013

ÖZKAN, METİN. "Predictive significance of VEGF and HIF-1 alpha expression in metastatic colorectal cancer patients receiving chemotherapy combined with bevacizumab." Journal of clınıcal oncology , *, United States Of America, 2013

ÖZKAN, M. (2013) . "Predictive significance of VEGF and HIF-1 alpha expression in metastatic colorectal cancer patients receiving chemotherapy combined with bevacizumab." Journal of clınıcal oncology , *, United States Of America.

@conferencepaper{conferencepaper, author={METİN ÖZKAN}, title={Predictive significance of VEGF and HIF-1 alpha expression in metastatic colorectal cancer patients receiving chemotherapy combined with bevacizumab}, congress name={Journal of clınıcal oncology}, city={*}, country={United States Of America}, year={2013}}